MDI and DPI Drug Products
...The guidance sets forth information that should be provided to ensure continuing drug.....An alternative approach may be used if such approach satisfies the requirements of the.....establish a set of criteria to which a drug substance or drug product should conform using..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=100)
þÿ
...18 The applicant and/or drug product manufacturer must establish the reliability of the.....its specification and, therefore, can be used in the manufacture of a given drug product.....Justification for an in-process test that is used in lieu of a drug substance test should..
http://www.fda.gov/cder/guidance/3969DFT.pdf (score=84)
þÿ
...18 The applicant and/or drug product manufacturer must establish the reliability of the.....its specification and, therefore, can be used in the manufacture of a given drug product.....Justification for an in-process test that is used in lieu of a drug substance test should..
http://www.fda.gov/OHRMS/DOCKETS/98fr/2003d-0571-gdl0001.pdf (score=81)
PET Drug Products … Current Good Manufacturing Practice (CGMP)
...ensure that each batch of PET drug product meets its established acceptance criteria, 1201.....used if such approach satisfies the requirements of the applicable statutes and.....or lot, of a PET drug typically consists of one multiple-dose vial containing the PET drug..
http://www.fda.gov/cder/guidance/4259dft.pdf (score=73)
PET Drug Products - Current Good Manufacturing Practice (CGMP)
...Critical activities in the production and testing of a PET drug product that expose the PET drug product or the sterile surface.....Equipment used in the production, processing, or packaging of a PET drug product should be.....An alternative approach may be used if such approach satisfies the requirements of the..
http://www.fda.gov/cder/guidance/4259dft.htm (score=70)
stability guidance -draft
...this guidance to mean a batch of drug substance or drug product manufactured at the scale typically encountered.....and the test methods used to monitor the stability of the drug product packaged in the.....and the test methods used to monitor the stability of the drug substance and preliminary..
http://www.fda.gov/cder/guidance/1707dft.pdf (score=67)
Guidance- Content & Format CMC for Vaccine & Related Product
...A list should be provided of all components in the drug product, including drug substance(s)and.....same areas used to produce the drug substance that is the subject of this application.....This section should contain information on the final drug product including all drug substances..
http://www.fda.gov/cber/gdlns/cmcvacc.pdf (score=58)
Substance
...individual batches of the drug substance used in animal and clinical testing, Drug.....relation to the amount of crude product, whether it is filtered while hot, whether a.....addresses new drug substances manufactured by chemical synthesis, by fermentation, or by..
http://www.fda.gov/cder/guidance/drugsub.pdf (score=56)
Document
...number in this manner would, code requirement, and we consider drug doses of the drug.....drugs are used in hospitals, so bar codes errors involving radiopharmaceuticals, bar codes.....manufacturer, product, and package. prevent the introduction, transmission, drug product..
http://www.fda.gov/OHRMS/DOCKETS/98fr/04-4249.pdf (score=54)
GUIDE TO INSPECTIONS OF BULK PHARMACEUTICAL CHEMICALS
...It would be unrealistic to expect drug product GMP concepts to apply to the production of these.....a substance that is represented as a drug and, when used, becomes an active ingredient or finished dosage.....It has been demonstrated that impurities in a finished drug product can cause degradation and..
http://www.fda.gov/ora/inspect_ref/igs/bulk.html (score=52)
...To ensure that a botanical drug product used in clinical trials is of consistently good quality, and.....A chemical constituent of a botanical raw material, drug substance, or drug product that is used for identification and/or quality.....The quality control tests performed on each batch of drug product, the analytical procedures..
http://www.fda.gov/cder/guidance/4592fnl.doc (score=50)
...To qualify for these statutory exemptions, a compounded drug product must satisfy several.....When evaluating a bulk drug substance used to treat a less serious illness, FDA will generally be more.....In short, FDA does not intend to take regulatory action against a drug product that has been..
http://www.fda.gov/ohrms/dockets/98fr/010799b.txt (score=41)
Guidance for Industry: Human Somatic Cell Therapy and Gene Therapy
...abbreviate testing and IND submission for a product or product series, the sponsor should.....Virus or DNA preparations used as preventive vaccines are not covered by this document.....Murphy, HFM-17, Center for Biologics Evaluation and Research, Food and Drug Administration..
http://www.fda.gov/cber/gdlns/somgene.pdf (score=41)
WAIS Document Retrieval
...To qualify for these statutory exemptions, a compounded drug product must satisfy several.....When evaluating a bulk drug substance used to treat a less serious illness, FDA will generally be more.....In short, FDA does not intend to take regulatory action against a drug product that has been..
http://www.fda.gov/cder/fdama/pclist.txt (score=40)
Guidance for Industry: Monoclonal Antibodies Used as Reagents in Drug...
...2 The term drug substance, which is used throughout the text, is intended to include biological products as defined.....specificity, avidity,microbiological safety), appropriate product comparability testing.....guidance, mAb reagents refers to monoclonal antibodies used as reagents in a drug..
http://www.fda.gov/cber/gdlns/mab032901.pdf (score=39)
PTC in Manufacture and Testing of Monoclonal Antibody Products for Human Use
...These trials cannot be used by themselves to support licensure of a product.Studies conducted in normal volunteers are not included in.....entity or is produced by a novel process, and when drug development plans are unusually.....separate product lots during drug development to demonstrate that a safe and effective..
http://www.fda.gov/cber/gdlns/ptc_mab.pdf (score=38)
GOOD MANUFACTURING PRACTICE GUIDE FOR ACTIVE PHARMACEUTICAL INGREDIENTS
...An alternative approach may be used if such..approach satisfies the requirements of the.....This draft guidance, when finalized, will represent the Food and Drug Administration=s.....product-related frequencies, and severity with a view to taking additional, 1360.. and if..
http://www.fda.gov/cder/guidance/4011dft.pdf (score=38)
Document
...351, 352, 353a, 355, nominated drug substances is limited, number and size of the bulk.....abstracts from reliable medical sources, substance has been used in pharmacy.. relevant.....through the new drug approval process, Academy of Compounding Pharmacists, rigorous and..
http://www.fda.gov/cder/fdama/pclist.pdf (score=37)
Pediatric Rule
...In the development of a new drug or biological product, decisions about appropriate populations to study and.....that are dangerous to health when used in the manner prescribed, recommended, or suggested.....inadequate dosage or regimen, prescribed a less effective drug, or did not prescribe a drug, due to the physician's..
http://www.fda.gov/cder/guidance/pedrule.pdf (score=37)
...only a limited characterization of the processes used to prepare the product for their ability to remove.....Sponsors should study a number of separate product lots during drug development to demonstrate that a safe and.....The areas used for final fill of drug products should follow the recommendations provided in the "Guidelines on..
http://www.fda.gov/cber/gdlns/ptc_mab.txt (score=36)
Powered by viXML, providing custom search results
Las Vegas Injury Lawyer
